|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tang M, Wang H, Cao Y, Zeng Z, Shan X and
Wang L: Nomogram for predicting occurrence and prognosis of liver
metastasis in colorectal cancer: A population-based study. Int J
Colorectal Dis. 36:271–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang Y, Zhao M, Yin J, Lu T, Yang X, Yuan
G, Li M, Liu Y, Zhan C and Wang Q: Pulmonary metastasis in newly
diagnosed colon-rectal cancer: A population-based nomogram study.
Int J Colorectal Dis. 34:867–878. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cao LL, Pei XF, Qiao X, Yu J, Ye H, Xi CL,
Wang PY and Gong ZL: SERPINA3 silencing inhibits the migration,
invasion, and liver metastasis of colon cancer cells. Dig Dis Sci.
63:2309–2319. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ding YL, Wang QS, Zhao WM and Xiang L:
Expression of smoothened protein in colon cancer and its prognostic
value for postoperative liver metastasis. Asian Pac J Cancer Prev.
13:4001–4005. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dobrokhotov O, Samsonov M, Sokabe M and
Hirata H: Mechanoregulation and pathology of YAP/TAZ via Hippo and
non-Hippo mechanisms. Clin Transl Med. 7:232018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Totaro A, Panciera T and Piccolo S:
YAP/TAZ upstream signals and downstream responses. Nat Cell Biol.
20:888–899. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim MK, Jang JW and Bae SC: DNA binding
partners of YAP/TAZ. BMB Rep. 51:126–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Ugalde AP, Scheele CLGJ, Dieter SM,
Nagel R, Ma J, Pataskar A, Korkmaz G, Elkon R, Chien MP, et al: A
comprehensive enhancer screen identifies TRAM2 as a key and novel
mediator of YAP oncogenesis. Genome Biol. 22:542021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsubaki M, Genno S, Takeda T, Matsuda T,
Kimura N, Yamashita Y, Morii Y, Shimomura K and Nishida S: Rhosin
suppressed tumor cell metastasis through inhibition of Rho/YAP
pathway and expression of RHAMM and CXCR4 in melanoma and breast
cancer cells. Biomedicines. 9:352021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng X, Arang N, Rigiracciolo DC, Lee JS,
Yeerna H, Wang Z, Lubrano S, Kishore A, Pachter JA, König GM, et
al: A platform of synthetic lethal gene interaction networks
reveals that the GNAQ uveal melanoma oncogene controls the Hippo
pathway through FAK. Cancer Cell. 35:457–472.e5. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hsu PC, Tian B, Yang YL, Wang YC, Liu S,
Urisman A, Yang CT, Xu Z, Jablons DM and You L: Cucurbitacin E
inhibits the Yes-associated protein signaling pathway and
suppresses brain metastasis of human non-small cell lung cancer in
a murine model. Oncol Rep. 42:697–707. 2019.PubMed/NCBI
|
|
13
|
Warren JSA, Xiao Y and Lamar JM: YAP/TAZ
activation as a target for treating metastatic cancer. Cancers
(Basel). 10:1152018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao J, Han W, He Y, Zhou J, Miao J and
Zhang G: Livin promotes tumor progression through YAP activation in
ovarian cancer. Am J Cancer Res. 10:3179–3193. 2020.PubMed/NCBI
|
|
15
|
Xu Z, Wang H, Gao L, Zhang H and Wang X:
YAP levels combined with plasma CEA levels are prognostic
biomarkers for early-clinical-stage patients of colorectal cancer.
Biomed Res Int. 2019:21708302019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Shi S, Guo Z, Zhang X, Han S, Yang
A, Wen W and Zhu Q: Overexpression of YAP and TAZ is an independent
predictor of prognosis in colorectal cancer and related to the
proliferation and metastasis of colon cancer cells. PLoS One.
8:e655392013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mouillet-Richard S and Laurent-Puig P:
YAP/TAZ signalling in colorectal cancer: Lessons from consensus
molecular subtypes. Cancers (Basel). 12:31602020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsubaki M, Ogawa N, Takeda T, Sakamoto K,
Shimaoka H, Fujita A, Itoh T, Imano M, Satou T and Nishida S:
Dimethyl fumarate induces apoptosis of hematopoietic tumor cells
via inhibition of NF-κB nuclear translocation and down-regulation
of Bcl-xL and XIAP. Biomed Pharmacother. 68:999–1005. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsubaki M, Komai M, Itoh T, Imano M,
Sakamoto K, Shimaoka H, Ogawa N, Mashimo K, Fujiwara D, Takeda T,
et al: Inhibition of the tumour necrosis factor-alpha autocrine
loop enhances the sensitivity of multiple myeloma cells to
anticancer drugs. Eur J Cancer. 49:3708–3717. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
You B, Yang YL, Xu Z, Dai Y, Liu S, Mao
JH, Tetsu O, Li H, Jablons DM and You L: Inhibition of ERK1/2
down-regulates the Hippo/YAP signaling pathway in human NSCLC
cells. Oncotarget. 6:4357–4368. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Y, Montminy T, Azad T, Lightbody E,
Hao Y, SenGupta S, Asselin E, Nicol C and Yang X: PI3K positively
regulates YAP and TAZ in mammary tumorigenesis through multiple
signaling pathways. Mol Cancer Res. 16:1046–1058. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsubaki M, Takeda T, Noguchi M, Jinushi M,
Seki S, Morii Y, Shimomura K, Imano M, Satou T and Nishida S:
Overactivation of Akt Contributes to MEK inhibitor primary and
acquired resistance in colorectal cancer cells. Cancers (Basel).
11:18662019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu-Chittenden Y, Huang B, Shim JS, Chen
Q, Lee SJ, Anders RA, Liu JO and Pan D: Genetic and pharmacological
disruption of the TEAD-YAP complex suppresses the oncogenic
activity of YAP. Genes Dev. 26:1300–1305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang C, Zhu X, Feng W, Yu Y, Jeong K, Guo
W, Lu Y and Mills GB: Verteporfin inhibits YAP function through
up-regulating 14-3-3σ sequestering YAP in the cytoplasm. Am J
Cancer Res. 6:27–37, eCollection 2016.2015. PubMed/NCBI
|
|
25
|
Leber MF and Efferth T: Molecular
principles of cancer invasion and metastasis (review). Int J Oncol.
34:881–895. 2009.PubMed/NCBI
|
|
26
|
Perlikos F, Harrington KJ and Syrigos KN:
Key molecular mechanisms in lung cancer invasion and metastasis: A
comprehensive review. Crit Rev Oncol Hematol. 87:1–11. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ming H, Li B, Zhou L, Goel A and Huang C:
Long non-coding RNAs and cancer metastasis: Molecular basis and
therapeutic implications. Biochim Biophys Acta Rev Cancer.
1875:1885192021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takeda T, Tsubaki M, Asano R, Itoh T,
Imano M, Satou T and Nishida S: Dimethyl fumarate suppresses
metastasis and growth of melanoma cells by inhibiting the nuclear
translocation of NF-κB. J Dermatol Sci. 99:168–176. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Coffey K: Targeting the Hippo pathway in
prostate cancer: What's new? Cancers (Basel). 13:6112021.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thompson BJ: YAP/TAZ: Drivers of tumor
growth, metastasis, and resistance to therapy. Bioessays.
42:e19001622020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sorrentino G, Ruggeri N, Zannini A,
Ingallina E, Bertolio R, Marotta C, Neri C, Cappuzzello E, Forcato
M, Rosato A, et al: Glucocorticoid receptor signalling activates
YAP in breast cancer. Nat Commun. 8:140732017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang S, Zhang L, Purohit V, Shukla SK,
Chen X, Yu F, Fu K, Chen Y, Solheim J, Singh PK, et al: Active YAP
promotes pancreatic cancer cell motility, invasion and
tumorigenesis in a mitotic phosphorylation-dependent manner through
LPAR3. Oncotarget. 6:36019–36031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu FX, Zhao B and Guan KL: Hippo pathway
in organ size control, tissue homeostasis, and cancer. Cell.
163:811–828. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li XJ, Leem SH, Park MH and Kim SM:
Regulation of YAP through an Akt-dependent process by 3,
3′-diindolylmethane in human colon cancer cells. Int J Oncol.
43:1992–1998. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qin X, Li J, Sun J, Liu L, Chen D and Liu
Y: Low shear stress induces ERK nuclear localization and YAP
activation to control the proliferation of breast cancer cells.
Biochem Biophys Res Commun. 510:219–223. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang C and Fakih M: Targeting KRAS in
colorectal cancer. Curr Oncol Rep. 23:282021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu YF, Yu BH, Li DL, Ke HL, Guo XZ and
Xiao XY: PI3K expression and PIK3CA mutations are related to
colorectal cancer metastases. World J Gastroenterol. 18:3745–3751.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pillaiyar T, Meenakshisundaram S, Manickam
M and Sankaranarayanan M: A medicinal chemistry perspective of drug
repositioning: Recent advances and challenges in drug discovery.
Eur J Med Chem. 195:1122752020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miller JW, Schmidt-Erfurth U, Sickenberg
M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B,
Donati G, Lane AM, et al: Photodynamic therapy with verteporfin for
choroidal neovascularization caused by age-related macular
degeneration: Results of a single treatment in a phase 1 and 2
study. Arch Ophthalmol. 117:1161–1173. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Brodowska K, Al-Moujahed A, Marmalidou A,
Meyer Zu Horste M, Cichy J, Miller JW, Gragoudas E and Vavvas DG:
The clinically used photosensitizer Verteporfin (VP) inhibits
YAP-TEAD and human retinoblastoma cell growth in vitro without
light activation. Exp Eye Res. 124:67–73. 2014. View Article : Google Scholar : PubMed/NCBI
|
